Guest guest Posted December 5, 2006 Report Share Posted December 5, 2006 Statins, the " Lower is better " Theory is not supported by changes in " calcified plaque " progression JoAnn Guest Sep 17, 2004 21:12 PDT --- Prescription Heart Drugs: --- Beta blockers and calcium channel blockers are the mainstay of conventional treatment for high blood pressure, heart disease, angina, and cardiac arrythmias for millions of americans. Calcium channel blockers claim to relax artery walls and lower blood pressure by blocking the 'entrance' of calcium into the cells! However, they also block some of the " essential functions " of the heart and arteries. Because of the side effects associated with these drugs, many patients taking calcium channel blockers have experienced a 60% higher risk of death from cardiac arrest. An effective " alternative " for the calcium channel blockers is MAGNESIUM. Magnesium is considerably more effective than prescription drugs. It's primary mode of action is helping to achieve " relaxation " of the smooth muscles of the arteries and 'reduced stress' on the myocrdium. This is accomplished in a gentle natural way without any accompanying side effects associated with popular prescription drugs (commonly called statins;). Reducing or eliminating excessive amounts of calcium and sodium rich foods while increasing your daily intake of magnesium, potassium and potassium rich foods tends to reduce oxidation of any existing arterial plaque. ------------------------- " Beta blockers " are frequently prescribed for high blood pressure. They block the ability of your heart to respond to epinephrine and adrenaline, which actually stimulates your 'pulse' rate and 'blood pressure', elevating both. This tends to bring on a condition where there is an " overall weakening " within the heart itself, so that blood 'pressure' is *lowered* and heart pain reduced. Beta blockers can be beneficial for 'temporary' relief, but that's not the way they're prescribed! Virtually every doctor I'm aware of prescribes them indefinitely! Dr. Julian Whitaker, M.D. www.drwhitaker.com ------------------------- Anti-hyperlipidemic drugs (Statins) are given with the intention of lowering lipid levels. --- These drugsall have extremely dangerous side effects, and again, there is SCANT 'evidence' that they reduce your overall risk of heart attack! In fact the " fine print " indicates otherwise! Do not rely on orthodox medicine's 'preconceived' assumptions. Statin drugs known as Mevacor, Lipitor and Zocor are high on the list of these popular " lipid-lowering " drugs. Statins reduce the " production " of lipids in the liver and inhibits the manner in which it 'enters' our cells. According to the " Physician's Desk Reference " (PDR), side effects of these drugs include liver *toxicity*, muscle " inflammation', gastrointestinal symptoms, and an increased risk of cataract formation. A significant " side effect " of statin drugs not mentioned in the PDR is a " reduction " in your body's production of 'Coenzyme Q10'. Co-Q10 is essential for healthy heart muscles. Co-Q10 is more prevalent in your heart muscles than any other muscle in our body!! ------------------------- Colestid and Questran (resins): absorb bile acids in the intestinal tract and cause them to be excreted, lowering lipid levels circulating in the blood however these same Resins have 'considerable' side effects, namely... constipation, nausea, bloating, and, more seriously, reduced absorption of vitamins A,D, E, and K. Over the long term, these deficiencies may cause bleeding disorders and vision problems! There was actually an " increased " 'death rate' from those taking Atromid-S although it was from 'non-cardiac' causes, primarily forms of *CANCER*! ------------------------- A More Safe Natural Approach: ------------------------------- We now know that cholesterol-lowering drugs have dangerous side effects and there is scant research that they lessen the risk of heart attack! There are safe alternatives that address the CAUSES of heart disease, not just the SYMPTOMS! They work to prevent and in some cases even 'reverse' heart disease. A nutrient dense diet rich in organic fruits and vegetables, a high-potency, antioxidant-rich multivitamin regimen, " essential fatty acid " supplementation along with moderate exercise greatly reduces our risks. www.udoerasmus.com ------------------------- Researchers: Diet Cuts Cholesterol as Well as Drug Tue Jul 22, 4:21 PM ------------------------ CHICAGO (Reuters) - The Mediterranean diet can reduce lipid levels about as effectively as lipid lowering drugs called statins, Canadian researchers said on Tuesday The diet containing natural " plant sterols " found in plants, organic vegetables and fruits, raw almonds, cold-pressed unrefined oils such as olive and sesame oils, in combination with the " viscous fibers " found in organic Oats, barley and psyllium, was credited with reducing lipid levels by 29 percent over four weeks in a group of 16 subjects. Another group of study participants who took a daily dose of 20 milligrams of the drug *lovastatin* lowered levels by a comparable 31 percent over four weeks. The findings suggested that patients try a dietary approach for six to 12 weeks before turning to lipid- lowering drugs, Dr. James Anderson, of the University of Kentucky in Lexington, wrote in an editorial accompanying the study published in the Journal of the American Medical Association. " Dietary management is an essential part of the treatment for lipid disorders, although adherence to strict and intensive dietary interventions requires motivation by patients, encouragement by physicians, and, perhaps, counseling by dietitians and nutrition experts, " Anderson wrote. ------------------------- High lipids are a known risk factor for cardiovascular disease, and statins reduce the risk of mortality from heart-related illnesses (short term) by up to one-third. Unfortunately however, there are many " documented dangers " involved in taking statin drugs. -- Study author David Jenkins wrote: " Using the experience gained,further development of a more natural dietary approach may provide a potentially valuable dietary option for cardiovascular disease risk reduction in primary prevention. " ------------------------- Posted: Fri Sep 17, 2004 7:01 pm Carcinogenicity of lipid-lowering drugs. -------------------------. Newman TB, Hulley SB. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi? cmd=Retrieve & db=PubMed & list_uids=8531288 & dopt=Abstract Department of Laboratory Medicine,School of Medicine, University of California, San Francisco, USA. OBJECTIVE--To review the findings and implications of studies of rodent carcinogenicity of lipid-lowering drugs. DATA SOURCES- Summaries of carcinogenicity studies published in the 1992 and 1994 Physicians' Desk Reference (PDR), additional information obtained from the US Food and Drug Administration, and published articles identified by computer searching, bibliographies, and consultation with experts. STUDY SAMPLE-- We tabulated 'rodent carcinogenicity' data from the 1994 PDR for all drugs listed as " hypolipidemics. " For comparison, we selected a stratified random sample of anti-hypertensive drugs. We also reviewed methods and interpretation of carcinogenicity studies in rodents and results of clinical trials in humans. DATA SYNTHESIS--All members of the two most popular classes of lipid- lowering drugs (the fibrates and the statins)cause cancer in rodents, in some cases at levels of animal exposure close to those prescribed to humans. CONCLUSIONS--Extrapolation of this evidence of carcinogenesis from rodents to humans is an uncertain process. Longer-term clinical trials and careful postmarketing surveillance during the next several decades are needed to determine whether lipid-lowering drugs cause cancer in humans. In the meantime, the results of experiments in animals and humans suggest that lipid-lowering drug treatment, especially with the fibrates and statins, should be avoided except in patients at high short-term risk of coronary heart disease. Publication Types: Review Review Literature PMID: 8531288 [PubMed ----------------------------- " Calcified Plaque " burden remains 'unchanged' by Statin drugs ------------------------- Relation of aggressiveness of lipid-lowering treatment to changes in calcified plaque burden by electron beam tomography. Hecht HS, Harman SM. Beth Israel Medical Center, New York, New York 10003, USA. hhe- ------------------------- The comparative effects of more versus less aggressive low-density lipoprotein (LDL) lowering (to </=80 vs >80 mg/dl) on calcified coronary plaque progression by electron beam tomography were evaluated in 182 consecutive asymptomatic patients after 1.2 years of treatment with statins alone or in combination with niacin. Despite the greater improvement in lipids in the </=80 versus >80 mg/dl groups, there were no differences in 'calcified plaque' progression (9.3%/year vs 9.1%/year). We conclude that, with respect to LDL lipid lowering with Statins, the " lower is better " theory is not supported by changes in calcified plaque progression. Publication Types: Clinical Trial PMID: 12888149 [PubMed - indexed for MEDLINE] _________________ JoAnn Guest mrsjo- http://www.geocities.com/mrsjoguest Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.